Financhill
Back

ADMA Biologics Quote, Financials, Valuation and Earnings

ADMA Biologics Price Quote

$21.04
-0.33 (-1.54%)
(Updated: November 21, 2024 at 10:15 AM ET)

ADMA Biologics Key Stats

Buy
73
ADMA Biologics (ADMA) is a Buy

Day range:
$20.47 - $21.40
52-week range:
$3.60 - $23.64
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13.25
P/B ratio:
21.78%

Volume:
2.2M
Avg. volume:
4.6M
1-year change:
430.27%
Market cap:
$5.1B
Revenue:
$258.2M
EPS:
$0.28

How Much Does ADMA Biologics Make?

Is ADMA Biologics Growing As A Company?

  • What Is ADMA Biologics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.78%
  • What Is ADMA Biologics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 14%

ADMA Biologics Stock Price Performance

  • Did ADMA Biologics Stock Go Up Last Month?
    ADMA Biologics share price went up by 35.42% last month
  • Did ADMA's Share Price Rise Over The Last Year?
    ADMA share price rose by 430.27% over the past 1 year

What Is ADMA Biologics 52-Week High & Low?

ADMA Biologics Price To Free Cash Flow

Is It Risky To Buy ADMA Biologics?

  • How Much Debt Does ADMA Biologics Have?
    Total long term debt quarterly is $101.3M
  • How Much Cash Does ADMA Biologics Have?
    Cash and short term investments quarterly total is $86.7M
  • What Is ADMA Biologics’s Book Value Per Share?
    Book value per share is 0.98

Is ADMA Biologics Cash Flow Positive?

  • What Is ADMA Cash Flow From Operations?
    Cash flow from operations (TTM) is $86.1M
  • What Is ADMA Biologics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$66.3M
  • What Is ADMA Biologics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$7.2M

ADMA Biologics Return On Invested Capital

  • Is Management Doing A Good Job?
    ADMA return on invested capital is 22.77%
  • What Is ADMA Biologics Return On Assets?
    ROA measures how assets are converting to revenues and is 18.97%
  • What Is ADMA Return On Equity?
    ROE is a measure of profitability and is 39.59%

ADMA Biologics Earnings Date & Stock Price

ADMA Biologics Competitors

  • Who Are ADMA Biologics's Competitors?
    Below is a list of companies who compete with ADMA Biologics or are related in some way:
    • Assembly Biosciences Inc (ASMB)
    • Corcept Therapeutics Inc (CORT)
    • Krystal Biotech Inc (KRYS)
    • Madrigal Pharmaceuticals Inc (MDGL)
    • TG Therapeutics Inc (TGTX)

ADMA Biologics Dividend Yield

ADMA Biologics Analyst Estimates

YoY Growth Past Surprise
EPS: 1400% 15.39%
Revenue: 78.13% 13.22%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 23.45
Upside from Last Price: 9.71%

Major Shareholders

  • How many ADMA shares are owned by institutional investors?
    367.3M ADMA shares are owned by institutional investors
  • How many ADMA shares are owned by insiders?
    4.6M ADMA shares are owned by insiders